Abstract:To examine the role of G(o) in modulation of ion channels by neurotransmitter receptors, we characterized modulation of ionic currents in hippocampal CA3 neurons from mice lacking both isoforms of Galpha(o). In CA3 neurons from Galpha(o)(-/-) mice, 2-chloro-adenosine and the GABA(B)-receptor agonist baclofen activated inwardly rectifying K(+) currents and inhibited voltage-dependent Ca(2+) currents just as effectively as in Galpha(o)(+/+) littermates. However, the kinetics of transmitter action were dramatical… Show more
“…G␣ i2 mutations designed to disrupt the domain-domain interaction accelerated GIRK activation rates consistent with the biochemical studies of mutant G␣ i1 subunits that increased basal GDP release rates (5). Thus our findings establish experimental conditions whereby the GPCR-catalyzed G␣ GDP release rate is the rate-limiting step in receptor-dependent GIRK activation as originally proposed by Breitwieser and Szabo (6) for I K,ACh in atrial myocytes, and importantly identifies molecular determinants that mediate functional differences in GIRK channels activated by GPCRs coupled to G␣ i and G␣ o proteins that may impact the kinetics and magnitude of inhibitory GIRK channel-mediated postsynaptic currents (7). FIG.…”
G␥-activated inwardly rectifying K؉ (GIRK) channels have distinct gating properties when activated by receptors coupled specifically to G␣ o versus G␣ i subunit isoforms, with G␣ o -coupled currents having ϳ3-fold faster agonist-evoked activation kinetics. To identify the molecular determinants in G␣ subunits mediating these kinetic differences, chimeras were constructed using pertussis toxin (PTX)-insensitive G␣ oA and G␣ i2 mutant subunits (G␣ oA(C351G) and G␣ i2(C352G) ) and examined in PTX-treated Xenopus oocytes expressing muscarinic m2 receptors and Kir3.1/3.2a channels. These experiments revealed that the ␣-helical N-terminal region (amino acids 1-161) and the switch regions of G␣ i2 (amino acids 162-262) both partially contribute to slowing the GIRK activation time course when compared with the G␣ oA(C351G) -coupled response. When present together, they fully reproduce G␣ i2(C352G) -coupled GIRK kinetics. The G␣ i2 C-terminal region (amino acids 263-355) had no significant effect on GIRK kinetics. Complementary responses were observed with chimeras substituting the G␣ o switch regions into the G␣ i2(C352G) subunit, which partially accelerated the GIRK activation rate. The G␣ oA /G␣ i2 chimera results led us to examine an interaction between the ␣-helical domain and the Ras-like domain previously implicated in mediating a 4-fold slower in vitro basal GDP release rate in G␣ i1 compared with G␣ o . Mutations disrupting the interdomain contact in G␣ i2(C352G) at either the ␣D-␣E loop (R145A) or the switch III loop (L233Q/A236H/E240T/ M241T), significantly accelerated the GIRK activation kinetics consistent with the G␣ i2 interdomain interface regulating receptor-catalyzed GDP release rates in vivo. We propose that differences in G␣ i versus G␣ o -coupled GIRK activation kinetics are due to intrinsic differences in receptor-catalyzed GDP release that rate-limit G␥ production and is attributed to heterogeneity in G␣ i and G␣ o interdomain contacts.Cardiac and neuronal G␥-gated inwardly rectifying K ϩ channels (GIRKs) 1 are activated by G protein-coupled receptors (GPCRs) selectively coupled to pertussis toxin (PTX)-sensitive G␣ i/o ␥ proteins (1, 2). The time course for GIRK channel activation elicited by application of receptor agonist can be influenced by the multiple intervening steps of the G protein cycle that begin with agonist binding to the GPCR, and end with G␥ binding to the GIRK channel subunits that promote gating transitions to the open state. In addition to the G protein activation steps, signal termination with GTP hydrolysis by the G␣ subunit and G␥ reassociation also impacts the kinetics and amplitude of agonist-activated GIRK currents. The ternary complex consisting of agonist, GPCR, and G protein influences the time course of agonist-elicited GIRK channel currents (3), supporting the notion that isoform composition of different GPCR-G␣ i/o ␥ protein-RGS protein-GIRK channel signaling complexes have different kinetic properties that affect their functional output (4). We recently repor...
“…G␣ i2 mutations designed to disrupt the domain-domain interaction accelerated GIRK activation rates consistent with the biochemical studies of mutant G␣ i1 subunits that increased basal GDP release rates (5). Thus our findings establish experimental conditions whereby the GPCR-catalyzed G␣ GDP release rate is the rate-limiting step in receptor-dependent GIRK activation as originally proposed by Breitwieser and Szabo (6) for I K,ACh in atrial myocytes, and importantly identifies molecular determinants that mediate functional differences in GIRK channels activated by GPCRs coupled to G␣ i and G␣ o proteins that may impact the kinetics and magnitude of inhibitory GIRK channel-mediated postsynaptic currents (7). FIG.…”
G␥-activated inwardly rectifying K؉ (GIRK) channels have distinct gating properties when activated by receptors coupled specifically to G␣ o versus G␣ i subunit isoforms, with G␣ o -coupled currents having ϳ3-fold faster agonist-evoked activation kinetics. To identify the molecular determinants in G␣ subunits mediating these kinetic differences, chimeras were constructed using pertussis toxin (PTX)-insensitive G␣ oA and G␣ i2 mutant subunits (G␣ oA(C351G) and G␣ i2(C352G) ) and examined in PTX-treated Xenopus oocytes expressing muscarinic m2 receptors and Kir3.1/3.2a channels. These experiments revealed that the ␣-helical N-terminal region (amino acids 1-161) and the switch regions of G␣ i2 (amino acids 162-262) both partially contribute to slowing the GIRK activation time course when compared with the G␣ oA(C351G) -coupled response. When present together, they fully reproduce G␣ i2(C352G) -coupled GIRK kinetics. The G␣ i2 C-terminal region (amino acids 263-355) had no significant effect on GIRK kinetics. Complementary responses were observed with chimeras substituting the G␣ o switch regions into the G␣ i2(C352G) subunit, which partially accelerated the GIRK activation rate. The G␣ oA /G␣ i2 chimera results led us to examine an interaction between the ␣-helical domain and the Ras-like domain previously implicated in mediating a 4-fold slower in vitro basal GDP release rate in G␣ i1 compared with G␣ o . Mutations disrupting the interdomain contact in G␣ i2(C352G) at either the ␣D-␣E loop (R145A) or the switch III loop (L233Q/A236H/E240T/ M241T), significantly accelerated the GIRK activation kinetics consistent with the G␣ i2 interdomain interface regulating receptor-catalyzed GDP release rates in vivo. We propose that differences in G␣ i versus G␣ o -coupled GIRK activation kinetics are due to intrinsic differences in receptor-catalyzed GDP release that rate-limit G␥ production and is attributed to heterogeneity in G␣ i and G␣ o interdomain contacts.Cardiac and neuronal G␥-gated inwardly rectifying K ϩ channels (GIRKs) 1 are activated by G protein-coupled receptors (GPCRs) selectively coupled to pertussis toxin (PTX)-sensitive G␣ i/o ␥ proteins (1, 2). The time course for GIRK channel activation elicited by application of receptor agonist can be influenced by the multiple intervening steps of the G protein cycle that begin with agonist binding to the GPCR, and end with G␥ binding to the GIRK channel subunits that promote gating transitions to the open state. In addition to the G protein activation steps, signal termination with GTP hydrolysis by the G␣ subunit and G␥ reassociation also impacts the kinetics and amplitude of agonist-activated GIRK currents. The ternary complex consisting of agonist, GPCR, and G protein influences the time course of agonist-elicited GIRK channel currents (3), supporting the notion that isoform composition of different GPCR-G␣ i/o ␥ protein-RGS protein-GIRK channel signaling complexes have different kinetic properties that affect their functional output (4). We recently repor...
“…Nevertheless, presynaptic as well as postsynaptic effects of adenosine observed in the rat are recapitulated in the mouse (Luscher et al, 1997;Greif et al, 2000;Jarolimek et al, 2000). Herein, we report that fEPSP responses evoked by Schaffer collateral/commissural stimulation are potently inhibited by adenosine, although the EC 50 for this response was higher than we observed previously in the rat (Dunwiddie et al, 1986;Brundege et al, 1997).…”
Excitatory glutamatergic synapses in the hippocampal CA1 region of rats are potently inhibited by purines, including adenosine, ATP, and ATP analogs. Adenosine A 1 receptors are known to mediate at least part of the response to adenine nucleotides, either because adenine nucleotides activate A 1 receptors directly, or activate them secondarily upon the nucleotides' conversion to adenosine. In the present studies, the inhibitory effects of adenosine, ATP, the purportedly stable ATP analog adenosine-5Ј-O-(3-thio)triphosphate (ATP␥S), and cyclic AMP were examined in mice with a null mutation in the adenosine A 1 receptor gene. ATP␥S displaced the binding of A 1 -selective ligands to intact brain sections and brain homogenates from adenosine A 1 receptor wild-type animals. In homogenates, but not in intact brain sections, this displacement was abolished by adenosine deaminase. In hippocampal slices from wild-type mice, purines abolished synaptic responses, but slices from mice lacking functional A 1 receptors showed no synaptic modulation by adenosine, ATP, cAMP, or ATP␥S. In slices from heterozygous mice the dose-response curve for both adenosine and ATP was shifted to the right. In all cases, inhibition of synaptic responses by purines could be blocked by prior treatment with the competitive adenosine A 1 receptor antagonist 8-cyclopentyltheophylline. Taken together, these results show that even supposedly stable adenine nucleotides are rapidly converted to adenosine at sites close to the A 1 receptor, and that inhibition of synaptic transmission by purine nucleotides is mediated exclusively by A 1 receptors.
“…A subtle, partial effect linked to G␣ 11 , unmasked in G␣ q knock-out mice, would be expected to be slower when compared with the G␣ q -mediated effect observed in their wild-type littermates, given the lower density of the G␣ 11 subtype in CA1 pyramidal neurons (Mailleux et al, 1992;Milligan, 1993;Tanaka et al, 2000). Indeed, a compensatory phenomenon with altered (slower) kinetics has been reported recently for the modulation of potassium and calcium channels by GABA B and adenosine receptors in hippocampal neurons from mice lacking G␣ o (Greif et al, 2000). This seems unlikely to occur in our case, because the time course of the residual muscarinic and glutamatergic effects on sI AHP was not different in G␣ q knock-out mice when compared with their wild-type littermates [compare Figs.…”
In hippocampal and other cortical neurons, action potentials are followed by a slow afterhyperpolarization (sAHP) generated by the activation of small-conductance Ca 2ϩ -activated K ϩ channels and controlling spike frequency adaptation. The corresponding current, the apamin-insensitive sI AHP , is a well known target of modulation by different neurotransmitters, including acetylcholine (via M 3 receptors) and glutamate (via metabotropic glutamate receptor 5, mGluR 5 ), in CA1 pyramidal neurons. The actions of muscarinic and mGluR agonists on sI AHP involve the activation of pertussis toxin-insensitive G-proteins. However, the pharmacological tools available so far did not permit the identification of the specific G-protein subtypes transducing the effects of M 3 and mGluR 5 on sI AHP . In the present study, we used mice deficient in the G␣ q and G␣ 11 genes to investigate the specific role of these G-protein ␣ subunits in the cholinergic and glutamatergic modulation of sI AHP in CA1 neurons. In mice lacking G␣ q , the effects of muscarinic and glutamatergic agonists on sI AHP were nearly abolished, whereas -adrenergic agonists acting via G␣ s were still fully effective. Modulation of sI AHP by any of these agonists was instead unchanged in mice lacking G␣ 11 . The additional depolarizing effects of muscarinic and glutamatergic agonists on CA1 neurons were preserved in mice lacking G␣ q or G␣ 11 . Thus, G␣ q , but not G␣ 11 , mediates specifically the action of cholinergic and glutamatergic agonists on sI AHP , without affecting the modulation of other currents. These results provide to our knowledge one of the first examples of the functional specificity of G␣ q and G␣ 11 in central neurons.
Key words: G-protein; muscarinic; metabotropic glutamate; calcium-activated potassium current; afterhyperpolarization; CA1 pyramidal neuronsIn the hippocampus, glutamatergic and cholinergic regulation of neuronal excitability is thought to play a pivotal role in learning and memory processes (Pin and
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.